Arnav Mehta

16PUBLICATIONS

134CO-AUTHORS

Molecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 29, 2026

Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors.

|Jun 24, 2026

Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

|Dec 11, 2025

Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer.

Alejandro Jiménez-Sánchez, Sitara Persad, Akimasa Hayashi

|Nov 18, 2025

Distinct Spatially Resolved Tumor Microenvironment Trajectories Define Benefit from Ramucirumab plus Pembrolizumab in Refractory PD-L1+ Gastric Cancer.

Sung Hee Lim, Minae An, You Jeong Heo

|Apr 08, 2025

The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application.

Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas

|Mar 18, 2025

Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial.

Sung Hee Lim, Minae An, Hyuk Lee

Pageof 3

Frequent Collaborators

Nir Hacohen

Hyuk Lee

Seung Tae Kim

You Jeong Heo

Samuel J Klempner

Kyoung-Mee Kim

Samuel Wright

Minae An

Moshe Sade-Feldman

Byung-Hoon Min

Frequent Collaborators

Nir Hacohen

Hyuk Lee

Seung Tae Kim

You Jeong Heo